Efficacy and Safety of Dextroamphetamine Transdermal System for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results from a Pivotal Phase 2 Study

OBJECTIVES: To assess efficacy and safety of the new Dextroamphetamine Transdermal System (d-ATS) to treat children and adolescents (aged 6–17 years) with attention-deficit/hyperactivity disorder (ADHD). METHODS: In this phase 2, randomized, placebo-controlled study, 4 d-ATS patches of differing dos...

Descripción completa

Detalles Bibliográficos
Autores principales: Cutler, Andrew J., Suzuki, Katsumi, Starling, Brittney, Balakrishnan, Kanan, Komaroff, Marina, Castelli, Mariacristina, Meeves, Suzanne, Childress, Ann C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972004/
https://www.ncbi.nlm.nih.gov/pubmed/35020462
http://dx.doi.org/10.1089/cap.2021.0107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972004/
https://www.ncbi.nlm.nih.gov/pubmed/35020462
http://dx.doi.org/10.1089/cap.2021.0107

Ejemplares similares